RefleXion PET/CT Imaging Performance in Patients With Various Malignancies

A Pilot Prospective Study of the RefleXion [18F]- FDG PET-CT Subsystem Imaging Performance in Patients With Various Malignancies

Not applicable Interventional City of Hope Medical Center · NCT05844306

This study is testing a new type of imaging called RefleXion PET/CT to see how well it works for people with different types of cancer.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment20 (estimated)
Ages21 Years and up
SexAll
SponsorCity of Hope Medical Center Academic / other
Drugs / interventionsradiation
Locations1 site (Duarte, California)
Trial IDNCT05844306 on ClinicalTrials.gov

What this trial studies

Processing failed - manual review needed

Who should consider this trial

Good fit: Unknown

Not a fit: Unknown

Why it matters

Potential benefit: Unknown

How similar studies have performed: Unknown

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Documented informed consent of the participant and/or legally authorized representative
* Age: \>= 21 years
* Patients with malignancies (abdominal/pelvic/thoracic/head and neck/breast tumors) undergoing SOC \[18F\]-FDG PET-CT for diagnostic and/or radiotherapy planning purposes
* Patients should be scheduled for \[18F\]-FDG PET-CT prior to study entry

Exclusion Criteria:

* Known psychiatric or substance abuse disorder that would interfere with conduct of the study
* Patient weight exceeding the weight limit (450 pounds) outlined per X1 RMRS specifications sheet
* Lung parenchymal and bone tumors will be excluded as their imaging characteristics were evaluated in a previous study

Where this trial is running

Duarte, California

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Hematopoietic and Lymphoid System NeoplasmMalignant Solid Neoplasm
Last reviewed 2026-06-09 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.